Company profile: Rebus Biosystems
1.1 - Company Overview
Company description
- Provider of spatial omics tools: Rebus Esper for single-cell data at subcellular resolution; Esper High Fidelity assay for spatial transcriptomics (up to 30 custom genes without barcoding or enzymatic amplification); Esper High Plex assay enabling analysis of 1230 gene panels; SAO microscopy enhancing resolution without sacrificing throughput; plus the Esper Service Program providing processed gene images and a spatially annotated CellxFeature matrix.
Products and services
- Esper High Plex Assay: Offers single-cell resolution over large sample areas, enabling analysis of 1,230-gene panels with customizable targets
- Rebus Esper: Automated spatial omics platform that generates quantitative single-molecule, single-cell datasets with subcellular resolution for spatial omics research
- SAO (Synthetic Aperture Optics): Optics-based microscopy system that enhances resolution without sacrificing throughput, using a sequence of high-resolution light patterns
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rebus Biosystems
Ansh Labs
HQ: United States
Website
- Description: Provider of immunoassays for research and clinical diagnostics, custom immunoassay development (optimization and validation), monoclonal antibodies, and research reagents (antibodies, antigens, proteins), plus animal-specific assays for veterinary diagnostics. Focus areas include reproductive medicine, neurodegenerative disorders, and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ansh Labs company profile →
Culture Biosciences
HQ: United States
Website
- Description: Provider of cloud-connected bioreactors and Console software enabling remote, real-time design, monitoring, and analysis of cell culture and bioprocess experiments, plus bioprocess development services including clone screening, process characterization, media screening, and process optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Culture Biosciences company profile →
Andor
HQ: United Kingdom
Website
- Description: Provider of scientific imaging equipment, designing and manufacturing high-performance cameras (EMCCD, CCD, sCMOS), integrated multimodal confocal microscopy systems for life sciences, spectroscopy platforms based on Czerny-Turner or Echelle spectrometers with advanced detectors, optical cryostats (<3 K to 500 K), photostimulation tools, and imaging/analysis software for scientific research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Andor company profile →
ChemoMetec
HQ: Denmark
Website
- Description: Provider of user-friendly instruments and software for precise cell counting and viability, including NucleoCounter NC-202 and NC-200 automated cell counters, XcytoMatic 40 for cell density analysis, Via2-Cassette disposable sampling cassettes, and NC-View/NucleoView image-analysis software, serving production/R&D, GMP, quality control, clinical diagnostics, cell therapy, and large pharmaceutical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemoMetec company profile →
LI-COR
HQ: United States
Website
- Description: Provider of highly engineered instrumentation systems, analysis software, and reagents for environmental and plant research, gas analysis, agriculture, drug discovery, protein research, and small animal imaging; used in more than 100 countries and on the International Space Station.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LI-COR company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rebus Biosystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rebus Biosystems
2.2 - Growth funds investing in similar companies to Rebus Biosystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rebus Biosystems
4.2 - Public trading comparable groups for Rebus Biosystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →